I use this buyer’s guide to help procurement, R&D, and quality teams evaluate 2,6-Bis(benzyloxy)pyridine-3-boronic acid, identified by CAS 2096339-92-1. The most important purchasing point is that a buyer should not approve this specialty boronic acid from the name alone; identity, assay, analytical data, packaging, and supply capability must be confirmed against the intended synthetic route. Because publicly available product information can vary by supplier, I recommend requesting a current specification sheet, lot-specific COA, SDS, sample policy, and commercial quotation before placing a bulk order.
For more information, please visit our website.
This guide is intended for pharmaceutical and fine-chemical companies, contract research organizations, process development laboratories, and distributors sourcing an advanced organic boronic acid. It is also useful for purchasing teams that need to compare catalogue material with custom or manufacturing-scale supply. I focus on practical verification rather than unsupported claims about performance, yield, or regulatory status.
For early-stage projects, the buyer may need only a small evaluation quantity to confirm reaction compatibility. For process development, the emphasis usually shifts to batch consistency, impurity control, documentation, and repeat availability. For commercial sourcing, the buyer should additionally assess manufacturing capacity, change-control communication, export documentation, and realistic lead times.
2,6-Bis(benzyloxy)pyridine-3-boronic acid is an aromatic heterocyclic boronic acid containing a pyridine ring, two benzyloxy substituents, and a boronic acid functional group. Its full chemical name and CAS number should appear consistently across the quotation, specification, label, COA, SDS, and shipping documents. I recommend treating CAS 2096339-92-1 as a primary identifier while also checking the structure and supplier’s internal product code.
Boronic acids are commonly selected as building blocks for carbon–carbon bond-forming chemistry, including Suzuki-type coupling strategies, although suitability depends on the reaction design and process conditions. The presence of a heteroaromatic ring and protected oxygen-containing substituents may make this compound relevant to medicinal chemistry and intermediate development. These possible uses do not replace experimental confirmation, so the buyer should evaluate the actual lot in the intended reaction system.
A useful specification sheet should distinguish confirmed product attributes from general handling guidance. At a minimum, I would request the product name, CAS number, molecular structure or formula, molecular weight, appearance, assay method, purity requirement, impurity profile, residual solvents, water content where relevant, and recommended storage conditions. If a supplier cannot provide a clear specification sheet, the buyer should ask which items are controlled release specifications and which are informational values.
I do not recommend inserting an assumed purity percentage, melting point, or storage temperature into an internal purchasing specification unless the supplier has confirmed it for the exact product and grade. For an initial evaluation, a buyer may request a 1 g to 5 g sample range, while production planning may involve 100 g, kilogram-level, or larger quantities depending on the route and forecast. These quantities are procurement examples, not claims about a standard package size for this compound.
A COA should be lot-specific rather than a generic document reused for every shipment. I first compare the COA product name, CAS number, lot number, manufacturing or retest date, quantity, and release date with the quotation and package label. Any mismatch should be resolved before the material enters the customer’s inventory.
For boronic acid building blocks, I pay particular attention to the analytical method and the way purity is reported. A chromatographic area percentage may not be identical to an absolute assay, and the buyer should understand whether water, solvent, or other components influence the reported result. If the COA contains only a single purity number without a method or specification limit, I ask for additional analytical clarification before making a qualification decision.
Where the project is sensitive to moisture or decomposition, I also request available stability or handling information. A supplier should not be expected to provide data that has not been generated, but the buyer can ask whether the material is moisture-sensitive, whether special packaging is used, and whether shipment conditions require controls such as protection from light or elevated temperature. If a customer needs a specific test, such as Karl Fischer water analysis or a defined chromatographic method, that requirement should be agreed before production.
If you want to learn more, please visit our website Maison Chemical.
Not every purchase needs the same level of documentation. A discovery project may prioritize fast sample access and a representative analytical package, while a regulated development program may require controlled specifications, formal change notification, and stronger batch traceability. I recommend defining the required grade before comparing prices because a lower quotation may exclude testing, packaging, or documentation required by the end user.
I advise buyers to avoid assuming that “high purity” has the same meaning across suppliers. The commercial specification should state the numerical limit, test method, and whether the result is a release test or a typical value. This approach makes supplier comparisons more transparent and reduces the risk of purchasing material that passes one supplier’s internal standard but does not meet the customer’s process needs.
My supplier evaluation starts with technical transparency, then moves to operational reliability and commercial fit. Maison Chemical can support inquiries for 2,6-Bis(benzyloxy)pyridine-3-boronic acid by clarifying available specifications, documentation, packaging options, sample quantities, and bulk-supply requirements. Final availability, price, MOQ, and lead time should be confirmed against the requested quantity, destination, and quality package.
Lead time should be treated as a planning variable rather than an assumed fixed number of days. I recommend asking for separate estimates for sample preparation, first commercial quantity, and repeat supply, because these stages may use different inventory or production arrangements. Buyers should also clarify whether the quoted lead time begins after purchase-order confirmation, technical approval, payment, or raw-material reservation.
Price should be compared on a delivered and documented basis. Important variables include quantity break, packaging, testing requirements, shipping method, destination, customs paperwork, and whether additional analytical work is charged separately. A quotation that clearly separates product cost, documentation, testing, and logistics is easier for procurement and quality teams to approve.
One common mistake is approving a supplier from a catalogue title without checking the lot-specific evidence. Another is requesting only a purity percentage while ignoring identity data, residual solvents, water, packaging, or traceability. A third is waiting until after the purchase order to specify the required COA format, which can create avoidable delays during quality review.
Buyers should also avoid treating a sample result as proof that every future batch will perform identically. A qualified supplier should be assessed through repeat-batch discussions, defined release criteria, and documented change-control expectations. If the compound is intended for a sensitive or scale-dependent synthesis, I recommend testing a representative lot under the customer’s own reaction conditions before committing to a larger forecast.
Prepare a concise inquiry that includes CAS 2096339-92-1, desired quantity, target purity or specification, intended use, destination country, required documents, packaging preference, and requested delivery window. Ask for the current specification sheet, SDS, sample or quotation options, and a representative COA where available. If the project has a defined analytical method or impurity limit, include it at the beginning of the technical discussion.
Maison Chemical can review your requirements for research quantities, process-development material, and bulk sourcing of 2,6-Bis(benzyloxy)pyridine-3-boronic acid. Contact our team with the target quantity and documentation requirements so we can confirm supply feasibility, commercial terms, packaging, and the appropriate quality package. The most reliable purchasing decision is one based on verified identity, agreed specifications, lot-specific documentation, and a supply plan that matches the project stage.
If you are looking for more details, kindly visit 2,6-Bis(benzyloxy)pyridine-3-boronic acid CAS 2096339-92-1.